vs

Side-by-side financial comparison of Cipher Mining Inc. (CIFR) and MEDIFAST INC (MED). Click either name above to swap in a different company.

MEDIFAST INC is the larger business by last-quarter revenue ($75.1M vs $59.7M, roughly 1.3× Cipher Mining Inc.). On growth, Cipher Mining Inc. posted the faster year-over-year revenue change (41.4% vs -36.9%). MEDIFAST INC produced more free cash flow last quarter ($-6.6M vs $-695.9M). Over the past eight quarters, Cipher Mining Inc.'s revenue compounded faster (11.4% CAGR vs -34.4%).

Cipher Mining, Inc. operates as a Bitcoin mining ecosystem in the United States. The firm is developing a cryptocurrency business.

Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics.

CIFR vs MED — Head-to-Head

Bigger by revenue
MED
MED
1.3× larger
MED
$75.1M
$59.7M
CIFR
Growing faster (revenue YoY)
CIFR
CIFR
+78.3% gap
CIFR
41.4%
-36.9%
MED
More free cash flow
MED
MED
$689.2M more FCF
MED
$-6.6M
$-695.9M
CIFR
Faster 2-yr revenue CAGR
CIFR
CIFR
Annualised
CIFR
11.4%
-34.4%
MED

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CIFR
CIFR
MED
MED
Revenue
$59.7M
$75.1M
Net Profit
$-734.2M
Gross Margin
59.4%
69.4%
Operating Margin
-503.4%
-10.4%
Net Margin
-1229.6%
Revenue YoY
41.4%
-36.9%
Net Profit YoY
-4293.1%
EPS (diluted)
$-1.91
$-1.64

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CIFR
CIFR
MED
MED
Q4 25
$59.7M
$75.1M
Q3 25
$71.7M
$89.4M
Q2 25
$43.6M
$105.6M
Q1 25
$49.0M
$115.7M
Q4 24
$42.2M
$119.0M
Q3 24
$24.1M
$140.2M
Q2 24
$36.8M
$168.6M
Q1 24
$48.1M
$174.7M
Net Profit
CIFR
CIFR
MED
MED
Q4 25
$-734.2M
Q3 25
$-3.3M
$-2.3M
Q2 25
$-45.8M
$2.5M
Q1 25
$-39.0M
$-772.0K
Q4 24
$17.5M
Q3 24
$-86.8M
$1.1M
Q2 24
$-15.3M
$-8.2M
Q1 24
$39.9M
$8.3M
Gross Margin
CIFR
CIFR
MED
MED
Q4 25
59.4%
69.4%
Q3 25
62.7%
69.5%
Q2 25
64.8%
72.6%
Q1 25
69.6%
72.8%
Q4 24
56.9%
74.1%
Q3 24
37.5%
75.4%
Q2 24
61.2%
73.2%
Q1 24
69.2%
72.8%
Operating Margin
CIFR
CIFR
MED
MED
Q4 25
-503.4%
-10.4%
Q3 25
-52.5%
-4.6%
Q2 25
-103.9%
-1.0%
Q1 25
-77.8%
-1.1%
Q4 24
40.5%
0.6%
Q3 24
-379.2%
1.5%
Q2 24
-43.9%
-4.7%
Q1 24
97.2%
4.5%
Net Margin
CIFR
CIFR
MED
MED
Q4 25
-1229.6%
Q3 25
-4.6%
-2.5%
Q2 25
-105.1%
2.3%
Q1 25
-79.6%
-0.7%
Q4 24
41.5%
Q3 24
-359.9%
0.8%
Q2 24
-41.5%
-4.8%
Q1 24
82.9%
4.8%
EPS (diluted)
CIFR
CIFR
MED
MED
Q4 25
$-1.91
$-1.64
Q3 25
$-0.01
$-0.21
Q2 25
$-0.12
$0.22
Q1 25
$-0.11
$-0.07
Q4 24
$0.04
$0.08
Q3 24
$-0.26
$0.10
Q2 24
$-0.05
$-0.75
Q1 24
$0.13
$0.76

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CIFR
CIFR
MED
MED
Cash + ST InvestmentsLiquidity on hand
$628.3M
$167.3M
Total DebtLower is stronger
$2.7B
Stockholders' EquityBook value
$805.5M
$198.9M
Total Assets
$4.3B
$248.0M
Debt / EquityLower = less leverage
3.37×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CIFR
CIFR
MED
MED
Q4 25
$628.3M
$167.3M
Q3 25
$1.2B
$173.5M
Q2 25
$62.7M
$162.7M
Q1 25
$23.2M
$164.6M
Q4 24
$5.6M
$162.3M
Q3 24
$25.3M
$170.0M
Q2 24
$122.6M
$163.5M
Q1 24
$88.7M
$156.4M
Total Debt
CIFR
CIFR
MED
MED
Q4 25
$2.7B
Q3 25
$1.0B
Q2 25
$167.1M
Q1 25
Q4 24
$0
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CIFR
CIFR
MED
MED
Q4 25
$805.5M
$198.9M
Q3 25
$783.2M
$214.7M
Q2 25
$748.9M
$216.0M
Q1 25
$734.8M
$211.0M
Q4 24
$682.0M
$210.1M
Q3 24
$672.0M
$207.3M
Q2 24
$690.8M
$205.3M
Q1 24
$600.9M
$211.0M
Total Assets
CIFR
CIFR
MED
MED
Q4 25
$4.3B
$248.0M
Q3 25
$2.8B
$268.2M
Q2 25
$1.0B
$269.3M
Q1 25
$913.8M
$280.0M
Q4 24
$855.4M
$284.2M
Q3 24
$775.4M
$291.2M
Q2 24
$775.6M
$293.5M
Q1 24
$677.1M
$302.8M
Debt / Equity
CIFR
CIFR
MED
MED
Q4 25
3.37×
Q3 25
1.31×
Q2 25
0.22×
Q1 25
Q4 24
0.00×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CIFR
CIFR
MED
MED
Operating Cash FlowLast quarter
$-207.9M
$-5.3M
Free Cash FlowOCF − Capex
$-695.9M
$-6.6M
FCF MarginFCF / Revenue
-1165.4%
-8.8%
Capex IntensityCapex / Revenue
817.1%
1.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-1.1B
$1.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CIFR
CIFR
MED
MED
Q4 25
$-207.9M
$-5.3M
Q3 25
$-50.1M
$12.1M
Q2 25
$-56.2M
$-3.4M
Q1 25
$-47.2M
$3.4M
Q4 24
$-87.5M
$-4.9M
Q3 24
$-6.5M
$9.1M
Q2 24
$-25.4M
$13.1M
Q1 24
$-26.6M
$7.3M
Free Cash Flow
CIFR
CIFR
MED
MED
Q4 25
$-695.9M
$-6.6M
Q3 25
$-256.2M
$10.8M
Q2 25
$-87.5M
$-4.8M
Q1 25
$-71.8M
$1.9M
Q4 24
$-227.0M
$-7.2M
Q3 24
$-83.2M
$7.7M
Q2 24
$-33.2M
$11.1M
Q1 24
$-34.5M
$5.4M
FCF Margin
CIFR
CIFR
MED
MED
Q4 25
-1165.4%
-8.8%
Q3 25
-357.3%
12.0%
Q2 25
-200.9%
-4.5%
Q1 25
-146.7%
1.6%
Q4 24
-537.6%
-6.1%
Q3 24
-345.0%
5.5%
Q2 24
-90.2%
6.6%
Q1 24
-71.7%
3.1%
Capex Intensity
CIFR
CIFR
MED
MED
Q4 25
817.1%
1.8%
Q3 25
287.5%
1.5%
Q2 25
71.8%
1.3%
Q1 25
50.2%
1.3%
Q4 24
330.4%
1.9%
Q3 24
317.8%
1.0%
Q2 24
21.4%
1.1%
Q1 24
16.4%
1.1%
Cash Conversion
CIFR
CIFR
MED
MED
Q4 25
Q3 25
Q2 25
-1.36×
Q1 25
Q4 24
-5.00×
Q3 24
8.04×
Q2 24
Q1 24
-0.67×
0.88×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons